Treatment Registry
TR-0169 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Injectco · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$425

Medication · Monthly program price (Tirzepatide Delivery page)$425

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly program price (Tirzepatide Delivery page)

$425 per month program

source

Per month$425Charged today$425
Visit Injectco

We earn nothing from this link. Injectco has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberBoth

Not yet checked: pharmacy, states, cancellation, membership and consult fee.

Recorded from injectco.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Injectco is a Texas medical-aesthetics chain with 9 physical TX locations (Argyle, Austin, Cleburne, Colleyville, Dallas, Fort Worth, Plano, Waxahachie, The Woodlands) that also sells GLP-1 delivery online. Pricing is inconsistent across the site: the general /glp-1-management/ landing page advertises a flat $1249 (promo, from $1599) for a '6 to 8 Month Supply' of an unspecified GLP-1, or $156/month on a payment plan; the dedicated compounded-semaglutide and tirzepatide-delivery service pages instead advertise flat $249/month and $425/month programs; and a location-specific Austin, TX page lists a $425/month all-inclusive in-person program for tirzepatide. None of these pages reconcile with each other, so all four price points are reported separately rather than picking one as authoritative. No cancellation/refund policy and no states-served list were found in the Terms of Service or elsewhere; only a 'Nationwide' patient-count marketing claim was found. Injection form (vial vs. pen) is never stated on any page checked. The /payment-plans/ page returned mostly leftover Stripe-docs boilerplate text with no InjectCo-specific pricing content.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0169
Readings
1

Related records

What else Injectco sells

All Injectco programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Injectco compounded tirzepatide (TR-0169). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0169

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.